Corporate Alliances

The Theramer^® combination of drug-like margins, device timelines, and versatile polymer chemistry represents an extraordinary business opportunity. The Theramer^® opportunity has been validated clinically, by the designation of Rimon's lead "drug-like" chronic wound dressing as a medical device by the US Food and Drug Administration, and as a result of the substantial interest expressed by a number of large medical device companies in Rimon's novel polymer platform.

Rimon offers potential corporate partners:

• Novel products that are ready for market
• Polymers that can enhance existing medical devices
• Technologies that are available for co-development for specific applications

The ability to develop value-added products over significantly reduced timelines underlies the advantage that Rimon's Theramers^® offer to potential strategic partners.

Please contact us if you would like to discuss the marketing, distribution or co-development of Rimon's technologies or products for specific applications.

"We have been building a network of corporate alliances with significant companies to drive our business development goals."
Steven Johnston, Director, Business Development